sapan shah

About

Dr. Sapan K. Shah, has been working as Assistant professor at Priyadarshini J. L. College of Pharmacy in the department of Pharmaceutical Chemistry, since September 2014. He also worked at S.K.B College of pharmacy Kamptee 2010-2014. He is university topper for the year 2008-2010 for M.Pharm examination (P'ceutical chemistry) at RTMNU. He is recipient of two gold medals, (a) Prof. G.B. Singh memorial & (b) Huseni H. Daginawala memorial medal. He had qualified GATE Examination in the year 2006 and 2007. He has published 08 books in the subject Pharmaceutical Sciences. He has published more than 30 research papers in national and international journals. He served as Co-Coordinator of AICTE-SPICES sponsored club ArogyaParigyan. He is also Coordinator of RTM Nagpur University approved course on Computer-Aided Drug Design. He got “Young Talent Award-2020 and 2021” for his outstanding contribution in Pharmacy fraternity. He has created learning platform QuickLearn360 for Pharmacy students. He conducted many seminars and workshop across national levels. His main area of research involves design of novel pharmaceutical drug molecules, (Physical and Chemical characterization), bioanalytical method development etc.

Employment

• PRIYADARSHINI J. L. COLLEGE OF PHARMACY ASSISTANT PROFESSOR
  2014 - Present
• SMT. KISHORITAI BHOYAR COLLEGE OF PHARMACY ASSISTANT PROFESSOR
  2010 - 2014
• RANBAXY PHARMACEUTICAL PVT LTD MEDICAL SERVICE REPRESENTATIVE
  2006 - 2009

Education

• PRIYADARSHINI J. L. COLLEGE OF PHARMACY M.PHARM
  2008 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• In silico Modeling for Dual Inhibition of Dipeptidyl Peptidase-4 and Xanthine Oxidase in Diabetes Mellitus
  Letters in Applied NanoBioScience 2026 DOI: 10.33263/LIANBS151.046
  +Save
• Cu₂O–phthalate coordination composite catalyzed synthesis of dihydropyrimidinone derivatives: Structural characterization, antimicrobial evaluation and molecular docking studies
  Next Materials 2026 DOI: 10.1016/j.nxmate.2026.103044
  +Save
• Author Correction: Multi-target in-silico modeling strategies to discover novel angiotensin converting enzyme and neprilysin dual inhibitors
  Scientific Reports 2024 DOI: 10.1038/s41598-024-71642-6
  +Save
• Multi-Target In-Silico modeling strategies to discover novel angiotensin converting enzyme and neprilysin dual inhibitors
  Scientific Reports 2024 DOI: 10.1038/s41598-024-66230-7
  +Save
• In silico study to recognize novel angiotensin-converting-enzyme-I inhibitors by 2D-QSAR and constraint-based molecular simulations
  Journal of Biomolecular Structure and Dynamics 2024 DOI: 10.1080/07391102.2023.2203261
  +Save
• Identification of structural scaffold from interbioscreen (IBS) database to inhibit 3CLpro, PLpro, and RdRp of SARS-CoV-2 using molecular docking and dynamic simulation studies
  Journal of Biomolecular Structure and Dynamics 2023 DOI: 10.1080/07391102.2023.2175377
  +Save
• Investigation of Neolamarckia cadamba phytoconstituents against SARS-CoV-2 3CL Pro: An In-Silico Approach
  Orbital: The Electronic Journal of Chemistry 2023 DOI: 10.17807/orbital.v15i1.17592
  +Save
• Prospecting for Cressa cretica to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2
  Journal of Biomolecular Structure and Dynamics 2022 DOI: 10.1080/07391102.2021.1872419
  +Save
• 2D-QSAR Modeling of Quinazolinone Derivatives as Angiotensin II Type 1a Receptor Blockers
  International Journal of Quantitative Structure-Property Relationships 2021 DOI: 10.4018/IJQSPR.290012
  +Save
• Challenges and Progress in Vaccine Development for COVID-19 Coronavirus (SARS-CoV-2): A Review
  The Open COVID Journal 2021 DOI: 10.2174/2666958702101010065
  +Save